Kyounggi-do, South Korea

Jei Man Ryu

This inventor holds 1 USPTO granted patent. Top assignee: Dongwha Pharm. Ind. Co., Ltd.. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jei Man Ryu. Retrieved from https://idiyas.com/inventor/jei-man-ryu-1udfotpe

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Jei Man Ryu in Pharmaceutical Composition

Introduction

Jei Man Ryu is a notable inventor based in Kyounggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions for medical use. His work focuses on enhancing the efficacy and comfort of drug administration.

Latest Patents

Jei Man Ryu holds a patent for a liquid suppository composition of diclofenac sodium. This invention comprises diclofenac sodium, poloxamer, and at least one polymer selected from polyethylene oxide and polyvinylpyrrolidone. The composition offers several advantages, including the absence of foreign matter or discomfort during rectal administration. Additionally, it ensures that the composition does not leak from the anus or shift into the end of the large intestine after administration.

Career Highlights

Jei Man Ryu is associated with Dongwha Pharmaceutical Industrial Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work has contributed to advancements in drug delivery systems, making treatments more effective and user-friendly.

Collaborations

Jei Man Ryu collaborates with esteemed colleagues such as Sung June Yoon and Jae Hee Jung. Their combined expertise fosters a productive environment for research and development in pharmaceutical innovations.

Conclusion

Jei Man Ryu's contributions to the field of pharmaceuticals, particularly through his patented liquid suppository composition, highlight his commitment to improving patient care. His innovative approach continues to influence the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…